person

Joaquin B. U.

Country
Spain
Department
Internal medicine- Infectious Disease Department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 18 partner sites.

Specializations

Hematologic Malignancies

The investigator concentrates on multiple myeloma and its high‑risk variants, advancing treatment options for refractory disease.

  • Acute myeloid leukemia
  • Chronic lymphocytic leukemia
  • Diffuse large B‑cell lymphoma
  • Myelodysplastic syndromes
  • Hairy cell leukemia

Research integrates targeted agents and immunotherapies to improve survival outcomes.

Solid Tumor Oncology

Key interests include breast cancer, especially hormone‑receptor positive and HER2‑negative subtypes.

  • Gastric adenocarcinoma
  • Non‑small cell lung cancer
  • Pancreatic ductal adenocarcinoma
  • Colorectal carcinoma
  • Thyroid neoplasms

Efforts emphasize precision medicine and novel antibody‑drug conjugates.

Infectious Diseases & Viral Infections

The investigator addresses challenges in HIV‑1 infection management and viral reactivation post‑transplant.

  • Cytomegalovirus infection
  • Hepatitis B virus
  • Respiratory viral pathogens
  • Opportunistic fungal infections
  • Antimicrobial resistance

Studies aim to optimize prophylaxis and therapeutic regimens.

Transplantation & Graft‑versus‑Host Disease

Focus is placed on allogeneic hematopoietic stem cell transplantation and mitigation of graft‑versus‑host complications.

  • Acute graft‑versus‑host disease
  • Chronic graft‑versus‑host disease
  • Transplant‑related infections
  • Immune reconstitution
  • Donor selection strategies

Research explores cellular and pharmacologic interventions to enhance transplant success.

Autoimmune Cytopenias & Hematologic Disorders

Investigations target immune thrombocytopenia and related autoimmune blood disorders.

  • Warm autoimmune hemolytic anemia
  • Essential thrombocythemia
  • Polycythemia vera
  • Paroxysmal nocturnal hemoglobinuria
  • Congenital antithrombin deficiency

Therapeutic development seeks durable remission with minimal toxicity.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.